Citadel Advisors’s ImmunoCellular Therapeutics, Ltd. IMUC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q4 | – | Sell |
-69,746
| Closed | -$15K | – | 5326 |
|
|
2018
Q3 | $15K | Sell |
69,746
-66,297
| -49% | -$14.3K | ﹤0.01% | 4180 |
|
|
2018
Q2 | $35K | Sell |
136,043
-258,612
| -66% | -$66.5K | ﹤0.01% | 3965 |
|
|
2018
Q1 | $99K | Buy |
+394,655
| New | +$99K | ﹤0.01% | 3636 |
|
|
2016
Q3 | – | Sell |
-1,051
| Closed | -$10K | – | 4548 |
|
|
2016
Q2 | $10K | Sell |
1,051
-2,176
| -67% | -$20.7K | ﹤0.01% | 3291 |
|
|
2016
Q1 | $37K | Buy |
+3,227
| New | +$37K | ﹤0.01% | 3057 |
|
|
2015
Q3 | – | Sell |
-290
| Closed | -$5K | – | 4643 |
|
|
2015
Q2 | $5K | Buy |
+290
| New | +$5K | ﹤0.01% | 3745 |
|
|
2015
Q1 | – | Sell |
-1,465
| Closed | -$43K | – | 4400 |
|
|
2014
Q4 | $43K | Buy |
1,465
+912
| +165% | +$26.8K | ﹤0.01% | 3436 |
|
|
2014
Q3 | $20K | Sell |
553
-162
| -23% | -$5.86K | ﹤0.01% | 3326 |
|
|
2014
Q2 | $32K | Buy |
715
+623
| +677% | +$27.9K | ﹤0.01% | 3199 |
|
|
2014
Q1 | $5K | Sell |
92
-1,776
| -95% | -$96.5K | ﹤0.01% | 3548 |
|
|
2013
Q4 | $69K | Buy |
1,868
+1,462
| +360% | +$54K | ﹤0.01% | 2715 |
|
|
2013
Q3 | $42K | Buy |
+406
| New | +$42K | ﹤0.01% | 2637 |
|